The research project aims to identify biomarkers related to Long COVID (CL) or Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). This 12-month study aims to deepen our understanding of the mechanisms of Long COVID (CL) or Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), which could lead to improved early detection and implementation of personalized management strategies, benefiting individuals affected by these conditions. To achieve these goals, the research project will leverage virtual twin technology and untargeted metabolomic profiling, with a particular focus on prognosis and monitoring.
Neurology
ME/CFS & Long COVID
The research project aims to identify biomarkers related to Long COVID (CL) or Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). This 12-month study aims to deepen our understanding of the mechanisms of Long COVID (CL) or Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), which could lead to improved early detection and implementation of personalized management strategies, benefiting individuals affected by these conditions. To achieve these goals, the research project will leverage virtual twin technology and untargeted metabolomic profiling, with a particular focus on prognosis and monitoring.
About This Research
Research Objective
To understand and improve outcomes for myalgic encephalomyelitis (chronic fatigue syndrome).
Expected Outcomes
- Identification of novel biomarkers profile
- Personalized allergy management
- Insights into cross-reactivity